927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study

B Kubuschok,E Von Der Heyde,D.A Hahn,C Langer,U Bockmühl,H Mueller-Huesmann,G Klautke,P-S Mauz,B Reuter,J Von Der Grün,D Beutner,J Büntzel,C-J Busch,B.F Tamaskovics,J Riera Knorrenschild,M.K Welslau,T.C Gauler,D Waldenberger,A Dietz

doi:10.1016/j.annonc.2023.09.2071

927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study

B Kubuschok, E Von Der Heyde + Show 17 more

https://doi.org/10.1016/j.annonc.2023.09.2071

Copy DOI

Journal: Annals of Oncology

Publication Date: Oct 1, 2023

Affiliation: University Hospital Augsburg, Praxis für Hämatologie und Onkologie, Klinikum Stuttgart, Universitätsklinikum Gießen und Marburg, Klinikum Kassel, Brüderkrankenhaus St. Josef Paderborn, Klinikum Chemnitz, Klinik für Psychosomatik, Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universitätsmedizin Göttingen, Südharz Klinikum, Heinrich Heine University Düsseldorf, Essen University Hospital, Bristol-Myers Squibb (Germany), University Hospital Leipzig

#Updated Results #Recurrent Squamous Cell Carcinoma + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.